Found 2 hits Enz. Inhib. hit(s) with Target = 'Somatostatin receptor type 2' and Ligand = 'BDBM50537060' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM50537060
(CHEMBL4575530)Show SMILES [H][C@@]12C[C@H](OC)[C@@]3(C)C(=O)[C@H](OC)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c5ccccc5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](OC(=O)OCCSSC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)C(N)=O)[C@@H](NC(=O)OC(C)(C)C)c1ccccc1 |r,c:13| Show InChI InChI=1S/C96H122N12O26S4/c1-51-69(45-96(125)79(132-88(121)57-29-19-14-20-30-57)77-94(9,78(112)75(127-11)72(51)93(96,7)8)70(126-10)44-71-95(77,50-129-71)133-53(3)110)130-89(122)76(74(56-27-17-13-18-28-56)108-90(123)134-92(4,5)6)131-91(124)128-39-40-135-136-47-66(80(99)113)104-86(119)68-49-138-137-48-67(105-81(114)61(98)41-54-25-15-12-16-26-54)85(118)102-64(42-55-34-36-59(111)37-35-55)83(116)103-65(43-58-46-100-62-32-22-21-31-60(58)62)84(117)101-63(33-23-24-38-97)82(115)107-73(52(2)109)87(120)106-68/h12-22,25-32,34-37,46,52,61,63-71,73-77,79,100,109,111,125H,23-24,33,38-45,47-50,97-98H2,1-11H3,(H2,99,113)(H,101,117)(H,102,118)(H,103,116)(H,104,119)(H,105,114)(H,106,120)(H,107,115)(H,108,123)/t52-,61-,63+,64+,65-,66+,67+,68+,69+,70+,71-,73+,74+,75-,76-,77+,79+,94-,95+,96-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| KEGG PC cid PC sid UniChem
| Article PubMed
| 0.970 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Tarveda Therapeutics
Curated by ChEMBL
| Assay Description Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 mins |
J Med Chem 62: 2708-2719 (2019)
Article DOI: 10.1021/acs.jmedchem.8b02036 BindingDB Entry DOI: 10.7270/Q2NK3JJ9 |
More data for this Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM50537060
(CHEMBL4575530)Show SMILES [H][C@@]12C[C@H](OC)[C@@]3(C)C(=O)[C@H](OC)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c5ccccc5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](OC(=O)OCCSSC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)C(N)=O)[C@@H](NC(=O)OC(C)(C)C)c1ccccc1 |r,c:13| Show InChI InChI=1S/C96H122N12O26S4/c1-51-69(45-96(125)79(132-88(121)57-29-19-14-20-30-57)77-94(9,78(112)75(127-11)72(51)93(96,7)8)70(126-10)44-71-95(77,50-129-71)133-53(3)110)130-89(122)76(74(56-27-17-13-18-28-56)108-90(123)134-92(4,5)6)131-91(124)128-39-40-135-136-47-66(80(99)113)104-86(119)68-49-138-137-48-67(105-81(114)61(98)41-54-25-15-12-16-26-54)85(118)102-64(42-55-34-36-59(111)37-35-55)83(116)103-65(43-58-46-100-62-32-22-21-31-60(58)62)84(117)101-63(33-23-24-38-97)82(115)107-73(52(2)109)87(120)106-68/h12-22,25-32,34-37,46,52,61,63-71,73-77,79,100,109,111,125H,23-24,33,38-45,47-50,97-98H2,1-11H3,(H2,99,113)(H,101,117)(H,102,118)(H,103,116)(H,104,119)(H,105,114)(H,106,120)(H,107,115)(H,108,123)/t52-,61-,63+,64+,65-,66+,67+,68+,69+,70+,71-,73+,74+,75-,76-,77+,79+,94-,95+,96-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| KEGG PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Tarveda Therapeutics
Curated by ChEMBL
| Assay Description Binding affinity to human SSTR2 expressed in CHO-K1 cells assessed as induction of SSTR2 internalization after 4 hrs by chemiluminescent assay |
J Med Chem 62: 2708-2719 (2019)
Article DOI: 10.1021/acs.jmedchem.8b02036 BindingDB Entry DOI: 10.7270/Q2NK3JJ9 |
More data for this Ligand-Target Pair | |